Literature DB >> 7019057

Acquired immunity to Salmonella typhimurium and delayed (footpad) hypersensitivity in BALB/c mice.

C E Hormaeche, M C Fahrenkrog, R A Pettifor, J Brock.   

Abstract

BALB/c mice are extremely susceptible to salmonella infections. Previous reports have suggested that this natural susceptibility is due to a defect in cell-mediated immunity (CMI) which correlates with their inability to develop a delayed (footpad) hypersensitivity reaction to a salmonella extract when immunized with attenuated salmonellae. We have shown that mice thus immunized are in fact highly resistant to superinfecting intravenous challenge with virulent organisms, at a time when the footpad test is still negative. The footpad test becomes positive 2-3 weeks later, after the appearance of CMI, which is already present at 1 week as measured by determining the fate of a superinfecting challenge in the RES. The positive footpad reactions that develop in BALB/c mice--and also in B10, and CBA and (B10XA/J)F1 mice--are transferable to normal recipients by thetasensitive spleen cells. However, although B10 mice give positive delayed hypersensitivity (DH) reactions, they are more susceptible to salmonellae of intermediate virulence than the DH negative BALB/c strain. We have also shown that previous reports which suggested that susceptible mice did not develop immunity when vaccinated with live organisms are probably due to the salmonella strain used for vaccination, which does not establish a carrier state. A strain which does establish a carrier state effectively immunizes the susceptible BALB/c strain against virulent challenge, indicating that natural susceptibility does not preclude the development of acquired immunity to reinfection. X

Entities:  

Mesh:

Year:  1981        PMID: 7019057      PMCID: PMC1555054     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Natural resistance to Salmonella infection, delayed hypersensitivity and Ir genes in different strains of mice.

Authors:  J Plant; A A Glynn
Journal:  Nature       Date:  1974-03-22       Impact factor: 49.962

2.  Requirement for adherent cells in the primary and secondary immune response in vitro.

Authors:  O Sjöberg; J Andersson; G Möller
Journal:  Eur J Immunol       Date:  1972-04       Impact factor: 5.532

3.  Effect of adjuvant on immunogenicity of a heat-killed salmonella vaccine.

Authors:  F M Collins
Journal:  J Infect Dis       Date:  1972-07       Impact factor: 5.226

Review 4.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

5.  Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice.

Authors:  F M Collins; G B Mackaness
Journal:  J Immunol       Date:  1968-11       Impact factor: 5.422

6.  Resistance of inbred mice to Salmonella typhimurium.

Authors:  H G Robson; S I Vas
Journal:  J Infect Dis       Date:  1972-10       Impact factor: 5.226

7.  Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells.

Authors:  A Cohen; M Schlesinger
Journal:  Transplantation       Date:  1970-07       Impact factor: 4.939

8.  Mechanisms in antimicrobial immunity.

Authors:  F M Collins
Journal:  J Reticuloendothel Soc       Date:  1971-07

9.  Effect of nonspecific stimulation on the defense mechanisms of inbred mice.

Authors:  S Medina; S I Vas; H G Robson
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

10.  Role of the macrophage in natural resistance to salmonellosis in mice.

Authors:  T Maier; H C Oels
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

View more
  9 in total

1.  Immune responses in BALB/c mice following immunization with aromatic compound or purine-dependent Salmonella typhimurium strains.

Authors:  D O'Callaghan; D Maskell; J Tite; G Dougan
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

2.  Moderate immunodeficiency does not increase susceptibility to Salmonella typhimurium aroA live vaccines in mice.

Authors:  M Izhar; L DeSilva; H S Joysey; C E Hormaeche
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

3.  Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice.

Authors:  D O'Callaghan; D Maskell; F Y Liew; C S Easmon; G Dougan
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

4.  An outer membrane protein (porin) as an eliciting antigen for delayed-type hypersensitivity in murine salmonellosis.

Authors:  V Udhayakumar; V R Muthukkaruppan
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

5.  Host response to infection with a temperature-sensitive mutant of Salmonella typhimurium in a susceptible and a resistant strain of mice.

Authors:  C Nauciel; F Vilde; E Ronco
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

6.  Toxicity of lipopolysaccharide and of soluble extracts of Salmonella typhimurium in mice immunized with a live attenuated aroA salmonella vaccine.

Authors:  P Mastroeni; B Villarreal-Ramos; J A Harrison; R Demarco de Hormaeche; C E Hormaeche
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Delayed-type hypersensitivity and immunity to Salmonella typhimurium.

Authors:  L M Killar; T K Eisenstein
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

8.  Major histocompatibility complex heterozygosity reduces fitness in experimentally infected mice.

Authors:  Petteri Ilmonen; Dustin J Penn; Kristy Damjanovich; Linda Morrison; Laleh Ghotbi; Wayne K Potts
Journal:  Genetics       Date:  2007-07-01       Impact factor: 4.562

9.  Infection-dependent phenotypes in MHC-congenic mice are not due to MHC: can we trust congenic animals?

Authors:  Erin E McClelland; Kristy Damjanovich; Kyle Gardner; Zack J Groesbeck; Maggie S Ma; Megan Nibley; Kelly S Richardson; Maureen Wilkinson; Linda C Morrison; Paul Bernhardt; Wayne K Potts
Journal:  BMC Immunol       Date:  2004-07-09       Impact factor: 3.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.